We're booking some big profits in a bank stock near record highs that we still love

Jim Cramer's Charitable Trust is trimming its Goldman Sachs position by selling 10 shares at roughly $835 each, leaving the trust with 200 GS shares and reducing the holding weight to about 4.4% from 4.6%. The sale locks in roughly a 48% gain on shares bought in December 2024 after GS recovered from an Oct. 14 Q3-earnings dip (low near $742) to trade near record highs; Cramer cited a near-overbought S&P Short Range Oscillator (3.02% vs. a 4% threshold) and will use proceeds to replenish cash while moving his rating to a hold-equivalent 2.

Analysis

Market structure: The trim of GS (selling 10 shares at ~$835, realizing ~48% on Dec‑2024 buys) is a small liquidity event but signals profit-taking into a late-cycle financials rally led by IB/dealmaking. Winners are large-cap banks with capital-markets franchises (GS, MS) and syndicate desks; losers are leverage-dependent regional lenders if rates or flows reverse. The S&P Short Range Oscillator at 3.02% (4% = overbought) implies limited upside without a mean reversion; risk‑on inflows should compress equity IV ~5–15% near-term and modestly tighten IG credit spreads if M&A issuance continues.

Risk assessment: Immediate risk (days) is a technical pullback if oscillator crosses >4% or a negative macro print (ISM, payrolls). Short‑term (weeks–months) tail risks: sudden deal cancellations, a Fed shock that lifts 2s30s by >30bp, or regulatory fines on banks — any could widen GS CDS by 25–75bps and knock 10–20% off price. Long term (quarters) depends on sustained M&A/ECM cadence; if deal volume normalizes to 2019 levels GS EPS can grow mid‑teens annually. Hidden dependencies: GS earnings sensitivity to capital markets fees (40–60% of quarterly revenue) and leverage exposure to market liquidity.

Trade implications: Direct: avoid initiating large unhedged longs in GS at current levels; prefer buying on pullbacks to $780–800 with a 6–8% stop and 6–12 month target $920–980 (15–20% upside). Options: sell 30–60 day covered calls if long GS (strike +5–7% above entry) to harvest IV; buy 3‑month 5% OTM puts as tail protection if holding >2% position. Pair trade: long GS (1–2% portfolio) vs short regional bank ETF (KRE or ticker-specific) 1:1 to hedge duration/loan book risk.

Contrarian angles: Consensus treats GS as a “bond‑proxy” bank rally beneficiary; missing nuance is outsized fee concentration — a weak M&A quarter would re-rate multiples quickly. Reaction is modestly overdone in the near term given momentum; price is vulnerable to a 5–10% mean reversion if market breadth narrows. Historical parallel: 2014‑15 deal spikes produced short cyclical pullbacks before structural gains — so use option overlays and size discipline to avoid being caught in a momentum unwind.

Key Decisions for Investors

• Establish a phased long in GS totaling 1–2% portfolio weight: tranche 50% at $800, 25% at $780, 25% at $750; set stop-loss at 7% below each tranche and a 6–12 month target of $920–980 (15–20% upside).
• If already long GS >2% portfolio, sell 30–60 day covered calls at strikes 5–7% above cost to capture premium and lower basis; simultaneously buy 3‑month 5% OTM puts sized to cover 50% of position as tail protection if market breadth deteriorates.
• Implement a relative-value pair: go long GS (size as above) and short a regional bank ETF (e.g., KRE) equal notional to hedge cyclical loan/branch risk; liquidate if GS/KRE spread narrows by 10% or if S&P oscillator breaches >4% for three consecutive sessions.
• Reduce broader cyclical financial exposure by 1–2% of portfolio if S&P Short Range Oscillator >4% or VIX <12 (overbought signals); redeploy cash into event-driven shorts or protective hedges over the next 2–6 weeks.